• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过10号染色体限制性片段长度多态性分析预测侵袭性少突胶质细胞瘤。病例研究。

Aggressive oligodendroglioma predicted by chromosome 10 restriction fragment length polymorphism analysis. Case study.

作者信息

Wu J K, Folkerth R D, Ye Z, Darras B T

机构信息

Department of Neurosurgery, New England Medical Center, Boston, Massachusetts.

出版信息

J Neurooncol. 1993 Jan;15(1):29-35. doi: 10.1007/BF01050260.

DOI:10.1007/BF01050260
PMID:8095979
Abstract

Oligodendrogliomas are indolent brain tumors with mean postoperative survival of about 5 years. However, the range of postoperative survivals is wide, suggesting that these tumors are heterogeneous in their biologic behavior. Using restriction fragment length polymorphism (RFLP) analysis, we studied a case of an oligodendroglioma with loss of chromosome 10 sequences, a finding that has only been reported in glioblastoma multiforme and anaplastic astrocytomas. Four and a half months after the initial surgery the patient returned with a recurrent tumor having classic radiologic and pathologic features of glioblastoma multiforme. Loss of chromosome 10 alleles in oligodendroglioma may be predictive of aggressive biologic behavior, even in the absence of recognized histopathologic characteristics of anaplasia, and may enable us to select more appropriate treatments for this group of patients.

摘要

少突胶质细胞瘤是一种生长缓慢的脑肿瘤,术后平均生存期约为5年。然而,术后生存期范围很广,这表明这些肿瘤的生物学行为存在异质性。我们利用限制性片段长度多态性(RFLP)分析研究了1例10号染色体序列缺失的少突胶质细胞瘤病例,该发现仅在多形性胶质母细胞瘤和间变性星形细胞瘤中报道过。初次手术后4个半月,患者因复发性肿瘤再次就诊,该肿瘤具有多形性胶质母细胞瘤典型的影像学和病理学特征。少突胶质细胞瘤中10号染色体等位基因的缺失可能预示着侵袭性生物学行为,即使在没有公认的间变组织病理学特征的情况下也是如此,这可能使我们能够为这组患者选择更合适的治疗方法。

相似文献

1
Aggressive oligodendroglioma predicted by chromosome 10 restriction fragment length polymorphism analysis. Case study.通过10号染色体限制性片段长度多态性分析预测侵袭性少突胶质细胞瘤。病例研究。
J Neurooncol. 1993 Jan;15(1):29-35. doi: 10.1007/BF01050260.
2
Glioblastomatous recurrence of oligodendroglioma remote from the original site: a case report.少突胶质细胞瘤远离原发部位的胶质母细胞瘤样复发:一例报告
Surg Neurol. 2006 Dec;66(6):627-30; discussion 630-1. doi: 10.1016/j.surneu.2006.02.049. Epub 2006 Oct 6.
3
A new der(1;7)(q10;p10) leading to a singular 1p loss in a case of glioblastoma with oligodendroglioma component.一例具有少突胶质细胞瘤成分的胶质母细胞瘤中,出现导致1p单一缺失的新的der(1;7)(q10;p10)。
Neuropathology. 2014 Apr;34(2):170-8. doi: 10.1111/neup.12060. Epub 2013 Sep 30.
4
Correlation of cytogenetic analysis and loss of heterozygosity studies in human diffuse astrocytomas and mixed oligo-astrocytomas.人类弥漫性星形细胞瘤和混合性少突-星形细胞瘤的细胞遗传学分析与杂合性缺失研究的相关性
Genes Chromosomes Cancer. 1992 Nov;5(4):357-74. doi: 10.1002/gcc.2870050412.
5
Loss of constitutional heterozygosity in human astrocytomas.人类星形细胞瘤中染色体杂合性的缺失。
Acta Neurochir (Wien). 1992;117(3-4):172-7. doi: 10.1007/BF01400616.
6
Gliosarcoma arising from oligodendroglioma (Oligosarcoma): A case report with genetic analyses.起源于少突胶质细胞瘤的胶质肉瘤(少突胶质肉瘤):一例基因分析病例报告
Pathol Int. 2018 Oct;68(10):567-573. doi: 10.1111/pin.12723. Epub 2018 Sep 23.
7
Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p.少突胶质细胞瘤的分子遗传学分析显示,19号染色体长臂(19q)和1号染色体短臂(1p)存在优先等位基因缺失。
Am J Pathol. 1994 Nov;145(5):1175-90.
8
Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas.间变性少突胶质细胞瘤患者化疗反应和生存的特定基因预测指标
J Natl Cancer Inst. 1998 Oct 7;90(19):1473-9. doi: 10.1093/jnci/90.19.1473.
9
Evidence for a tumor suppressor gene on chromosome 19q associated with human astrocytomas, oligodendrogliomas, and mixed gliomas.与人类星形细胞瘤、少突胶质细胞瘤和混合性胶质瘤相关的位于19号染色体q臂上的肿瘤抑制基因的证据。
Cancer Res. 1992 Aug 1;52(15):4277-9.
10
Nogo-A: a useful marker for the diagnosis of oligodendroglioma and for identifying 1p19q codeletion.Nogo-A:少突胶质细胞瘤诊断的有用标志物,可用于鉴定 1p19q 联合缺失。
Hum Pathol. 2012 Mar;43(3):374-80. doi: 10.1016/j.humpath.2011.05.007. Epub 2011 Aug 10.

引用本文的文献

1
Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p.少突胶质细胞瘤的分子遗传学分析显示,19号染色体长臂(19q)和1号染色体短臂(1p)存在优先等位基因缺失。
Am J Pathol. 1994 Nov;145(5):1175-90.

本文引用的文献

1
Postoperative survival of patients with intracranial oligodendroglioma with special reference to radical tumor removal; a study of 26 patients.颅内少突胶质细胞瘤患者的术后生存情况,特别提及肿瘤根治性切除;26例患者的研究
J Neurosurg. 1951 Sep;8(5):473-9. doi: 10.3171/jns.1951.8.5.0473.
2
Oligodendrogliomas. I. A clinical study of cerebral oligodendrogliomas.少突胶质细胞瘤。一、大脑少突胶质细胞瘤的临床研究。
Cancer. 1980 Mar 15;45(6):1458-66. doi: 10.1002/1097-0142(19800315)45:6<1458::aid-cncr2820450627>3.0.co;2-0.
3
Role of radiation therapy in the treatment of cerebral oligodendroglioma: an analysis of 57 cases and a literature review.
Neurosurgery. 1983 Nov;13(5):499-503. doi: 10.1227/00006123-198311000-00003.
4
Grading of oligodendrogliomas.少突胶质细胞瘤的分级
Cancer. 1983 Dec 1;52(11):2107-14. doi: 10.1002/1097-0142(19831201)52:11<2107::aid-cncr2820521123>3.0.co;2-x.
5
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.一种将DNA限制性内切酶片段放射性标记至高比活度的技术。
Anal Biochem. 1983 Jul 1;132(1):6-13. doi: 10.1016/0003-2697(83)90418-9.
6
Oligodendroglioma: incidence and biological behavior in a defined population.少突胶质细胞瘤:特定人群中的发病率及生物学行为
J Neurosurg. 1985 Dec;63(6):881-9. doi: 10.3171/jns.1985.63.6.0881.
7
A clinicopathological study of 323 patients with oligodendrogliomas.323例少突胶质细胞瘤患者的临床病理研究
Ann Neurol. 1986 Jan;19(1):15-21. doi: 10.1002/ana.410190104.
8
Oligodendroglioma. Histologic evaluation and prognosis.
J Neuropathol Exp Neurol. 1986 Jan;45(1):65-78. doi: 10.1097/00005072-198601000-00006.
9
Clinicopathologic correlations in the oligodendroglioma.
Cancer. 1987 Apr 1;59(7):1345-52. doi: 10.1002/1097-0142(19870401)59:7<1345::aid-cncr2820590719>3.0.co;2-a.
10
Oligodendroglioma. An analysis of the value of radiation therapy.
Cancer. 1987 Nov 1;60(9):2179-88. doi: 10.1002/1097-0142(19871101)60:9<2179::aid-cncr2820600912>3.0.co;2-g.